The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial
Abstract
Purpose: The safety and efficacy of radical laparoscopic distal gastrectomy (LG) with D2 lymphadenectomy for the treatment of advanced gastric cancer (AGC) remain controversial. We conducted a randomized controlled trial to compare laparoscopic and conventional open distal gastrectomy with D2 lymph node dissections for AGC. Patients and Methods: Between September 2012 and December 2014, 1,056 patients with clinical stage T2-4aN0-3M0 gastric cancer were eligible for inclusion. They were randomly assigned to either the LG with D2 lymphadenectomy group (n = 528) or the open gastrectomy (OG) with D2 lymphadenectomy group (n = 528). Fifteen experienced surgeons from 14 institutions in China participated in the study. The morbidity and mortality within 30 days after surgery between the LG (n = 519) and the OG (n = 520) groups were compared on the basis of the modified intention-to-treat principle. Postoperative complications were stratified according to the Clavien-Dindo classification. Results: The compliance rates of D2 lymphadenectomy were similar between the LG and OG groups (99.4% v 99.6%; P = .845). The postoperative morbidity was 15.2% in the LG group and 12.9% in OG group with no significant difference (difference, 2.3%; 95% CI, –1.9 to 6.6; P = .285). The mortality rate was 0.4% for the LG group and zero for the OG group (difference, 0.4%; 95% CI, –0.4 to 1.4; P = .249). The distribution of severity was similar between the two groups (P = .314). Conclusion: Experienced surgeons can safely perform LG with D2 lymphadenectomy for AGC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Dindo, D., Demartines, N., & Clavien, P.-A. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000133083.54934.ae · Cited by 31,378
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
Cunningham, D., Allum, W. H., Stenning, S. P., Thompson, J. N., Van de Velde, C. J. H., Nicolson, M., Scarffe, J. H., Lofts, F. J., Falk, S. J., Iveson, T. J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055531 · Cited by 6,334
Macdonald, J. S., Smalley, S. R., Benedetti, J., Hundahl, S. A., Estes, N. C., Stemmermann, G. N., Haller, D. G., Ajani, J. A., Gunderson, L. L., Jessup, J. M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010187 · Cited by 3,475
Adjuvant Chemotherapy for Gastric Cancer with S-1, an Oral Fluoropyrimidine
Sakuramoto, S., Sasako, M., Yamaguchi, T., Kinoshita, T., Fujii, M., Nashimoto, A., Furukawa, H., Nakajima, T., Ohashi, Y., Imamura, H., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072252 · Cited by 2,517
Japanese gastric cancer treatment guidelines 2010 (ver. 3)
Japanese Gastric Cancer Association (2011) · Gastric Cancer · doi:10.1007/s10120-011-0042-4 · Cited by 2,168
Songun, I., Putter, H., Kranenbarg, E. M.-K., Sasako, M., & van de Velde, C. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70070-x · Cited by 1,765
Bang, Y.-J., Kim, Y.-W., Yang, H.-K., Chung, H. C., Park, Y.-K., Lee, K. H., Lee, K.-W., Kim, Y. H., Noh, S.-I., Cho, J. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61873-4 · Cited by 1,705
for the Surgical Co-operative Group, Cuschieri, A., Weeden, S., Fielding, J., Bancewicz, J., Craven, J., Joypaul, V, Sydes, M., & Fayers, P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690243 · Cited by 1,373
Hartgrink, H. H., van de Velde, C. J. H., Putter, H., Bonenkamp, J. J., Klein Kranenbarg, E., Songun, I., Welvaart, K., van Krieken, J. H. J. M., Meijer, S., Plukker, J. T. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.026 · Cited by 918
Huscher, C. G. S., Mingoli, A., Sgarzini, G., Sansonetti, A., Di Paola, M., Recher, A., & Ponzano, C. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000151892.35922.f2 · Cited by 860
Kim, H.-H., Hyung, W. J., Cho, G. S., Kim, M. C., Han, S.-U., Kim, W., Ryu, S.-W., Lee, H.-J., & Song, K. Y. (2010) · Annals of Surgery · doi:10.1097/sla.0b013e3181cc8f6b · Cited by 758
Sano, T., Sasako, M., Yamamoto, S., Nashimoto, A., Kurita, A., Hiratsuka, M., Tsujinaka, T., Kinoshita, T., Arai, K., Yamamura, Y., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.10.184 · Cited by 672
A Multicenter Study on Oncologic Outcome of Laparoscopic Gastrectomy for Early Cancer in Japan
Kitano, S., Shiraishi, N., Uyama, I., Sugihara, K., & Tanigawa, N. (2007) · Annals of Surgery · doi:10.1097/01.sla.0000225364.03133.f8 · Cited by 665
Kim, Y.-W., Baik, Y. H., Yun, Y. H., Nam, B. H., Kim, D. H., Choi, I. J., & Bae, J.-M. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e318185e62e · Cited by 608
Kitano, S., Shiraishi, N., Fujii, K., Yasuda, K., Inomata, M., & Adachi, Y. (2002) · Surgery · doi:10.1067/msy.2002.120115 · Cited by 604
Cancer Incidence in Five Continents. Comparability and quality of data.
Dm, P., & Cs, M. (1992) · PubMed · Cited by 505
Bozzetti, F., Marubini, E., Bonfanti, G., Miceli, R., Piano, C., & Gennari, L. (1999) · Annals of Surgery · doi:10.1097/00000658-199908000-00006 · Cited by 428
Lee, J. H., Han, H. S., & Lee, J. H. (2005) · Surgical Endoscopy · doi:10.1007/s00464-004-8808-y · Cited by 425
Kim, M. C., Kim, W., Kim, H. H., Ryu, S. W., Ryu, S. Y., Song, K. Y., Lee, H. J., Cho, G. S., Han, S. U., Hyung, W. J., et al. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0075-z · Cited by 200
Kim, W., Song, K. Y., Lee, H.-J., Han, S. U., Hyung, W. J., & Cho, G. S. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181887516 · Cited by 170
Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer
Sun, P., Xiang, J.-B., & Chen, Z.-Y. (2008) · British journal of surgery · doi:10.1002/bjs.6408 · Cited by 112
Jentschura, D., Winkler, M., Strohmeier, N., Rumstadt, B., & Hagmüller, E. (1997) · PubMed · Cited by 102
Cited by
Wang, F., Shen, L., Li, J., Zhou, Z., Liang, H., Zhang, X., Tang, L., Xin, Y., Jin, J., Zhang, Y., et al. (2019) · Cancer Communications · doi:10.1186/s40880-019-0349-9 · Cited by 810
Self-citationYu, J., Huang, C., Sun, Y., Su, X., Cao, H., Hu, J., Wang, K., Suo, J., Tao, K., He, X., et al. (2019) · JAMA · doi:10.1001/jama.2019.5359 · Cited by 690
Self-citationAjani, J. A., Lee, J., Sano, T., Janjigian, Y. Y., Fan, D., & Song, S. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.36 · Cited by 594
Korean Practice Guideline for Gastric Cancer 2018: an Evidence-based, Multi-disciplinary Approach
Guideline Committee of the Korean Gastric Cancer Association (KGCA), D. W. G. &. R. P. (2019) · Journal of Gastric Cancer · doi:10.5230/jgc.2019.19.e8 · Cited by 392
Korean Practice Guidelines for Gastric Cancer 2022: An Evidence-based, Multidisciplinary Approach
Kim, T.-H., Kim, I.-H., Kang, S. J., Choi, M., Kim, B.-H., Eom, B. W., Kim, B. J., Min, B.-H., Choi, C. I., Shin, C. M., et al. (2023) · Journal of Gastric Cancer · doi:10.5230/jgc.2023.23.e11 · Cited by 288
Self-citation
Metadata
- Authors
- Hu, Y., Huang, C., Sun, Y., Su, X., Cao, H., Hu, J., Xue, Y., Suo, J., Tao, K., He, X., Wei, H., Ying, M., Hu, W., Du, X., Chen, P., Liu, H., Zheng, C., Liu, F., Yu, J., Li, Z., Zhao, G., Chen, X., Wang, K., Li, P., Xing, J., & Li, G.
- Venue
- Journal of Clinical Oncology
- Published
- 2016-04-20
- Volume
- 34
- Issue
- 12
- Pages
- 1350-1357
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2287250785
- Cited by
- 686
- References
- 24
- FWCI
- 61.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.